Next Quarterly Earnings
Pre-market — typically before 3:30 p.m. German time (before the US open at 9:30 a.m. New York time).
Moderna is a US-based biotechnology company specializing in the development of groundbreaking mRNA therapeutics and vaccines. Through its innovative mRNA technology, the company drives medical research forward to offer preventive and therapeutic solutions for various diseases. It is recognized for its contribution to global healthcare.
Pre-market — typically before 3:30 p.m. German time (before the US open at 9:30 a.m. New York time).
Moderna is scheduled to report its next quarterly earnings on 10/29/2026. Pre-market — typically before 3:30 p.m. German time (before the US open at 9:30 a.m. New York time).
Moderna last reported quarterly earnings on 7/31/2026 (Q2 2026). Earnings per share (EPS) came in at -1.97 USD.
Across its last 4 earnings reports, Moderna stock moved by ±3.8% on average the following day. The largest reaction was -5.4% on 07/31/2026; 2 of 4 reactions were positive.
Moderna has beaten analyst EPS estimates in 5 of its last 5 evaluated quarters (beat rate: 100%).
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
Basis: price reactions to the last 4 report dates (close to close).
Basis: 5 quarters with an analyst estimate and reported EPS.
Past price reactions are not a reliable indicator of future performance.